This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "MCODE FHIR IG Proposal"

From HL7Wiki
Jump to navigation Jump to search
Line 78: Line 78:
  
 
<!-- What commitment does the WG have to maintaining this IG as the FHIR core specification continues to evolve - particularly if the initial project sponsors are no longer providing resources.  I.e. Who will be maintaining this IG content 5 years after it's published? -->
 
<!-- What commitment does the WG have to maintaining this IG as the FHIR core specification continues to evolve - particularly if the initial project sponsors are no longer providing resources.  I.e. Who will be maintaining this IG content 5 years after it's published? -->
 +
 +
mCODE is a large, highly visible initiative sponsored by the American Society of Clinical Oncology (ASCO) and developed in partership with the MITRE Corporation, in consultation with the Biden Cancer Initiative and the National Cancer Institute (NCI). ASCO has has established a governance body for mCODE through its Executive Committee, and there is commitment from the CIC WG to maintain the IG. Specifically, the MITRE Corporation is committed to maintaining the mCODE IG.
  
 
==Short Description==
 
==Short Description==

Revision as of 13:27, 29 May 2019



HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE)

Owning work group name

Clinical Interoperability Council

Committee Approval Date:

May 23 2019

Publishing Lead

Publishing Facilitator (per PSS): Laura Heerman Langford (Laura dot Heermann at imail dot org)

Technical IG Publisher Lead: Chris Moesel (cmoesel at mitre dot org)

Contributing or Reviewing Work Groups

  • Clinical Information Modeling Initiative WG
  • Clinical Genomics WG
  • Public Health WG

FHIR Development Project Insight ID

1509 [1]

Scope of coverage

This IG covers elements that are key for cancer management and care according to US clinical practice, including patient demographics, details about the disease and treatment, as well as outcomes. It is intended to provide a standard for data gathered from clinician-patient interactions that take place during routine healthcare delivery, and leveraging this "real world data" for other applications, such as quality measurement, comparative effectiveness research, and shared decision making. The IG aligns with other relevant US-realm FHIR IGs, such as the Argonaut Data Query IG.

Content location

https://github.com/HL7/fhir-mCODE-ig

Proposed IG realm and code

us/mcode

Maintenance Plan

mCODE is a large, highly visible initiative sponsored by the American Society of Clinical Oncology (ASCO) and developed in partership with the MITRE Corporation, in consultation with the Biden Cancer Initiative and the National Cancer Institute (NCI). ASCO has has established a governance body for mCODE through its Executive Committee, and there is commitment from the CIC WG to maintain the IG. Specifically, the MITRE Corporation is committed to maintaining the mCODE IG.

Short Description

Long Description

Involved parties

This guide was authored by the MITRE Corporation with extensive content expertise provided by the American Society for Clinical Oncology (ASCO), CancerLinQ, and with input and contributions from the HL7 community, including the Clinical Interoperability Council WG (sponsor), the Cancer Interoperability Project Group, Clinical Information Modeling Initiative WG (co-sponsor), the Clinical Genomics WG, and the Public Health WG.

Expected implementations

  • Intermountain Health Care
  • Partners Healthcare
  • CancerLinQ

Content sources

Example Scenarios

IG Relationships

This IG depends on the Argonaut Data Query IG. There are also some inter-dependencies with the Genomics Reporting FHIR IG.

Timelines

June 27 2019

When IG Proposal Is Complete

When you have completed your proposal, please send an email to FMGcontact@HL7.org

FMG Notes